FDA Approved: BIVALIRUDIN — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original application for BIVALIRUDIN by Eugia US LLC, granting a generic version of the anticoagulant for approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heparin-induced Thrombocytopenia

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)